-
demonstrates Zarxio is
biosimilar to Neupogen. In 2018, filgrastim-aafi (
Nivestym) was
approved for use in the
United States. In
September 2008, Ratiograstim...
-
nitrosulfathiazole (INN)
nitroxinil (INN)
nitroxoline (INN)
nivacortol (INN)
Nivestim Nivestym nivimedone (INN) Nix
nixylic acid (INN)
nizatidine (INN)
nizofenone (INN)...
- on June 11, 2020.
Retrieved November 26, 2023. "Drug
Approval Package:
Nivestym (filgrastim-aafi)". U.S. Food and Drug
Administration (FDA).
February 21...
-
Retrieved 2019-06-28.
Medscape (23
April 2019). "Neupogen, Granix, Zarxio,
Nivestym (filgrastim, tbo-filgrastim, filgrastim-sndz, filgrastim-aafi, G-CSF) dosing...
